Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Bicycle Therapeutics plc (BCYC)
Skynner Michael — CHIEF TECHNOLOGY OFFICER
Shares
3,045
Price
$6.80
Total Value
$20.71K
Shares Held After
165,232
% of Holdings
1.8%
Bicycle Therapeutics plc (BCYC)
Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER
Shares
1,317
Price
$6.80
Total Value
$8.96K
Shares Held After
67,380
% of Holdings
1.9%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
4,080
Price
$75.20
Total Value
$306.82K
Shares Held After
187,371
% of Holdings
2.1%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
955
Price
$38.36
Total Value
$36.63K
Shares Held After
50,365
% of Holdings
1.9%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
1,295
Price
$16.70
Total Value
$21.63K
Shares Held After
25,000
% of Holdings
4.9%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
8,080
Price
$15.92
Total Value
$128.63K
Shares Held After
26,295
% of Holdings
23.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
100
Price
$32.39
Total Value
$3.24K
Shares Held After
671,907
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,191
Price
$31.79
Total Value
$69.65K
Shares Held After
672,007
% of Holdings
0.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,709
Price
$30.47
Total Value
$387.24K
Shares Held After
674,198
% of Holdings
1.9%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
200
Price
$39.60
Total Value
$7.92K
Shares Held After
51,320
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
21
Price
$186.59
Total Value
$3.92K
Shares Held After
44,100
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,920
Price
$74.13
Total Value
$142.33K
Shares Held After
191,451
% of Holdings
1.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$28.96
Total Value
$289.61K
Shares Held After
69,744
% of Holdings
12.5%
Fulcrum Therapeutics, Inc. (FULC)
Gould Robert J — Director
Shares
15,000
Price
$11.87
Total Value
$178.09K
Shares Held After
469,864
% of Holdings
3.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$38.48
Total Value
$769.65K
Shares Held After
80,000
% of Holdings
20.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,394
Price
$41.92
Total Value
$100.35K
Shares Held After
447,133
% of Holdings
0.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
65,832
Price
$38.42
Total Value
$2.53M
Shares Held After
460,828
% of Holdings
12.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
5,715
Price
$80.09
Total Value
$457.71K
Shares Held After
33,243
% of Holdings
14.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Bjork Elisabeth — Director
Shares
10,000
Price
$3.44
Total Value
$34.40K
Shares Held After
50,000
% of Holdings
20.0%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Anzalone Christopher Richard — Director
Shares
7,416
Price
$65.88
Total Value
$488.57K
Shares Held After
3,798,510
% of Holdings
0.2%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$7.43
Total Value
$123.78K
Shares Held After
1,308,103
% of Holdings
1.3%
Janux Therapeutics, Inc. (JANX)
Dobek Maria — Vice President, Accounting
Shares
1,462
Price
$13.73
Total Value
$20.07K
Shares Held After
15,373
% of Holdings
8.7%
Janux Therapeutics, Inc. (JANX)
McIver Zachariah — Chief Medical Officer
Shares
2,714
Price
$13.73
Total Value
$37.26K
Shares Held After
23,286
% of Holdings
10.4%
Janux Therapeutics, Inc. (JANX)
Winter Charles M. — Chief Technical Officer
Shares
2,401
Price
$13.73
Total Value
$32.97K
Shares Held After
77,721
% of Holdings
3.0%
Janux Therapeutics, Inc. (JANX)
Campbell David Alan — Director
Shares
8,072
Price
$13.73
Total Value
$110.83K
Shares Held After
284,982
% of Holdings
2.8%
Janux Therapeutics, Inc. (JANX)
DiRaimondo Thomas — Chief Scientific Officer
Shares
2,505
Price
$13.73
Total Value
$34.39K
Shares Held After
124,425
% of Holdings
2.0%
Janux Therapeutics, Inc. (JANX)
Meyer Andrew Hollman — Chief Business Officer
Shares
1,879
Price
$13.73
Total Value
$25.80K
Shares Held After
83,095
% of Holdings
2.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
913
Price
$62.09
Total Value
$56.69K
Shares Held After
50,440
% of Holdings
1.8%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
4,000
Price
$28.00
Total Value
$112.00K
Shares Held After
61,740
% of Holdings
6.1%
Showing 1151–1179 of 1179 transactions (page 24 of 24)